Echtzeit-Aktienkurs CIPHER MINING INC.
Bid:
Ask:
Echtzeit-Chart der CIPHER MINING INC. Aktie
Fundamentaldaten der CIPHER MINING INC. Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 [USD] | - | -296,21 Mio. | -296,43 Mio. | -4,87 | - | - | - |
| 2017 [USD] | 1,62 Mio. | -288,24 Mio. | -288,88 Mio. | -4,95 | - | - | - |
| 2016 [USD] | 0,11 Mio. | -156,07 Mio. | -156,25 Mio. | -3,23 | - | - | - |
| 2015 [USD] | - | -85,47 Mio. | -85,47 Mio. | -2,11 | - | - | - |
| 2014 [USD] | 54,71 Mio. | 8,91 Mio. | 8,91 Mio. | 0,30 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der CIPHER MINING INC. Aktie
Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder plays two roles: As a biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. The work being done at Alder today will help those who suffer from cancer, autoimmune diseases, and inflammatory diseases. As a licensing partner, Alder is revolutionizing the way the pharmaceutical industry discovers, develops and produces antibody therapeutics. Through various licensing agreements, Alder has used its proprietary technology to help major biopharmaceutical partners advance novel therapeutics to the clinic in less time and at lower cost. Alder's licensing strategy also includes identifying strategic partners to assist in the development and marketing of its preclinical and clinical pipeline programs.